Panacea Life Sciences Holdings, Inc. Long-Term Debt, Maturity, Year Two
Panacea Life Sciences Holdings, Inc. (PLSH) had Long-Term Debt, Maturity, Year Two of $68.39 thousand as of 2021-03-31, per its 10-Q/A filed 2021-05-27.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2021-05-27
- 2021-03-31: Long-Term Debt, Maturity, Year Two $68.39K; Long-Term Debt, Maturity, Year Two as first filed $155.50K.
- 2020-12-31: Long-Term Debt, Maturity, Year Two $155.50K.
- 2020-09-30: Long-Term Debt, Maturity, Year Two $155.50K.
- 2020-06-30: Long-Term Debt, Maturity, Year Two $155.50K.
| Period end | Long-Term Debt, Maturity, Year Two | Long-Term Debt, Maturity, Year Two as first filed |
|---|---|---|
| 2021-03-31 | $68.39K 10-Q/A · filed 2021-05-27 | $155.50K 10-Q · filed 2021-05-24 |
| 2020-12-31 | $155.50K 10-K/A · filed 2021-04-23 | |
| 2020-09-30 | $155.50K 10-Q · filed 2020-11-18 | |
| 2020-06-30 | $155.50K 10-Q · filed 2020-08-19 |